Eli Lilly winner in FOYA Awards

Eli Lilly's IE2B development in Kinsale, Ireland has won the Innovation Category title. PM Group was Construction Manager for this project. Congratulations to all the Category Winners. The Overall Winner will be announced later this year.

Eli Lilly - IE2B

This new synthetic peptide manufacturing platform/facility is located at Eli Lilly’s existing facility in Kinsale, Ireland.  It utilizes a hybrid manufacturing platform, liquid phase peptide synthesis/solid phase peptide synthesis (LPPS/SPPS). This new manufacturing platform enables a significantly increased annual throughput potential and substantially reduces risks during the peptide manufacturing process.

The project was completed safely and resulted in the successful installation of several new process and execution systems. As Construction Manager, PM Group worked closely with Eli Lilly and our project partners to ensure a strong safety culture on the project which was executed during the COVID-19 pandemic.

The project involved over 1.6 million construction hours with a workforce of over 600 people at peak. The team collaborated effectively to ensure a “safety first” culture. A primary project objective was to ensure a safe workplace for the IE2B workforce. Executing the project in an existing operating campus added to the level of complexity during implementation.

Read more about this on the FOYA website: https://ispe.org/facility-year-awards/winners/2024/innovation

 

 

About the ISPE Facility of The Year Awards:

ISPE's Facility of the Year Awards is an annual program that recognizes state-of-the-art projects utilizing new, innovative technologies to improve the quality of products, to reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery.

More info: https://ispe.org/facility-year-awards